These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Molecular and cytogenetic events in urologic tumors. Klein EA; Fair WR; Chaganti RS Semin Urol; 1988 Feb; 6(1):2-21. PubMed ID: 2838875 [No Abstract] [Full Text] [Related]
5. The role of imaging in the surveillance of urologic malignancies. Bradford TJ; Montie JE; Hafez KS Urol Clin North Am; 2006 Aug; 33(3):377-96. PubMed ID: 16829272 [TBL] [Abstract][Full Text] [Related]
6. [Clinical effect of long-term administration of PSK in a combination in patients with malignant urologic cancer]. Niijima T; Koiso K; Ueno A; Kawabe K; Umeda T; Kobayashi K; Akaza H Gan To Kagaku Ryoho; 1982 Mar; 9(3):540-2. PubMed ID: 7184410 [TBL] [Abstract][Full Text] [Related]
16. [Basic research in uro-oncology--molecular biology emphasis and gene transfer techniques]. Gschwend JE; Fair WR Urologe A; 1996 Sep; 35(5):355-6. PubMed ID: 8999625 [No Abstract] [Full Text] [Related]
17. Altered expression of beta-catenin in renal cell cancer and transitional cell cancer with the absence of beta-catenin gene mutations. Bilim V; Kawasaki T; Katagiri A; Wakatsuki S; Takahashi K; Tomita Y Clin Cancer Res; 2000 Feb; 6(2):460-6. PubMed ID: 10690524 [TBL] [Abstract][Full Text] [Related]